Pharma Aids Limited (DSE:PHARMAID)
Bangladesh
· Delayed Price · Currency is BDT 543.00
+7.50 (1.40%)
At close: Jul 2, 2025
Pharma Aids Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
Net Income | 53.09 | 61.19 | -6.38 | 34.76 | 50.26 | 52.47 | Upgrade
|
Depreciation & Amortization | 6.5 | 6.92 | 7.62 | 7.82 | 8.25 | 8.57 | Upgrade
|
Other Operating Activities | -8.22 | -4.82 | -6.51 | -3.69 | -4.8 | 8.73 | Upgrade
|
Change in Accounts Receivable | 9.87 | 1.63 | -2.54 | 6.21 | 11.85 | - | Upgrade
|
Change in Inventory | -29.1 | -17.47 | 6.5 | -15.18 | -27.67 | 11.16 | Upgrade
|
Change in Accounts Payable | -1.84 | 3.89 | 0.24 | 1.25 | -0.26 | -39.95 | Upgrade
|
Change in Other Net Operating Assets | -30.07 | -28.55 | 8.33 | 2.67 | -6.22 | -0.3 | Upgrade
|
Operating Cash Flow | 0.23 | 22.79 | 7.27 | 33.85 | 31.41 | 40.69 | Upgrade
|
Operating Cash Flow Growth | -99.24% | 213.55% | -78.53% | 7.77% | -22.82% | 62.07% | Upgrade
|
Capital Expenditures | -3.48 | -0.18 | -2.21 | -4.7 | -10.28 | -5 | Upgrade
|
Sale of Property, Plant & Equipment | 0.55 | - | - | - | - | 0.3 | Upgrade
|
Other Investing Activities | 0.11 | 0.11 | 0.2 | 0.37 | 4.6 | -2.9 | Upgrade
|
Investing Cash Flow | -16.32 | -0.07 | -2.01 | -4.33 | -5.68 | -7.6 | Upgrade
|
Short-Term Debt Issued | - | - | 0.49 | 0.68 | - | 1.39 | Upgrade
|
Total Debt Issued | 16.82 | - | 0.49 | 0.68 | - | 1.39 | Upgrade
|
Short-Term Debt Repaid | - | -0.28 | - | - | -4.78 | -16.41 | Upgrade
|
Total Debt Repaid | -0.04 | -0.28 | - | - | -4.78 | -16.41 | Upgrade
|
Net Debt Issued (Repaid) | 16.78 | -0.28 | 0.49 | 0.68 | -4.78 | -15.03 | Upgrade
|
Common Dividends Paid | -7.84 | -4.83 | -15.54 | -25.27 | -15.05 | -18.91 | Upgrade
|
Other Financing Activities | - | - | - | - | - | 5.15 | Upgrade
|
Financing Cash Flow | 8.94 | -5.11 | -15.05 | -24.59 | -19.83 | -28.79 | Upgrade
|
Miscellaneous Cash Flow Adjustments | -0 | - | 0 | - | - | - | Upgrade
|
Net Cash Flow | -7.15 | 17.61 | -9.79 | 4.93 | 5.89 | 4.3 | Upgrade
|
Free Cash Flow | -3.25 | 22.6 | 5.06 | 29.15 | 21.12 | 35.69 | Upgrade
|
Free Cash Flow Growth | - | 346.82% | -82.64% | 37.97% | -40.81% | 53.16% | Upgrade
|
Free Cash Flow Margin | -0.78% | 5.37% | 1.64% | 9.02% | 7.54% | 13.24% | Upgrade
|
Free Cash Flow Per Share | -1.04 | 7.25 | 1.62 | 9.34 | 6.77 | 11.44 | Upgrade
|
Cash Interest Paid | 1.19 | 0.26 | 0.24 | 0.24 | 0.9 | 0.89 | Upgrade
|
Cash Income Tax Paid | 32.79 | 32.43 | 23.71 | 25.15 | 23.17 | 13.1 | Upgrade
|
Levered Free Cash Flow | -26.88 | 5.59 | 9.86 | 20.13 | 17.39 | 21.6 | Upgrade
|
Unlevered Free Cash Flow | -26.13 | 5.75 | 10.01 | 20.37 | 17.95 | 22.16 | Upgrade
|
Change in Net Working Capital | 75.67 | 53.72 | 2.07 | 16.52 | 21.47 | 26.31 | Upgrade
|
Updated Jan 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.